GBT
Global Blood Therapeutics, Inc.
Delisted
GBT was delisted on the 4th of October, 2022.
96 hedge funds and large institutions have $367M invested in Global Blood Therapeutics, Inc. in 2016 Q4 according to their latest regulatory filings, with 26 funds opening new positions, 42 increasing their positions, 18 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
3% less call options, than puts
Call options by funds: $759K | Put options by funds: $785K
25% less capital invested
Capital invested by funds: $488M → $367M (-$121M)
Holders
96
Holding in Top 10
3
Calls
$759K
Puts
$785K
Top Buyers
| 1 | +$14.4M | |
| 2 | +$11.5M | |
| 3 | +$10.5M | |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$8.43M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4.95M |
Top Sellers
| 1 | -$8.62M | |
| 2 | -$6.86M | |
| 3 | -$5.66M | |
| 4 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$4.61M |
| 5 |
Asset Management One
Tokyo,
Japan
|
-$2.67M |